Dr. Yaffe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
77 Massachusetts Ave, 76-353
Cambridge, MA 02139Phone+1 617-452-2103- Is this information wrong?
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Surgical Critical Care, 1995 - 1996
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Surgery, 1991 - 1995
- Beth Israel Deaconess Medical CenterResidency, Surgery, 1989 - 1991
- Case Western Reserve University School of MedicineClass of 1989
Certifications & Licensure
- MA State Medical License 1996 - 2025
- OH State Medical License 1992 - 1996
- American Board of Surgery Surgery
- American Board of Surgery Surgical Critical Care
Publications & Presentations
PubMed
- Cytomegalovirus durably primes neutrophil oxidative burst.Thomas F Marandu, Michael Dombek, Michael Gutknecht, Marion Griessl, Ingred Goretti Riça, Barbora Vlková, Kristína Macáková, Eleni Panagioti, Alec Griffith, James Lede...> ;Journal of Leukocyte Biology. 2023 Oct 26
- 1 citationsBiphasic JNK-Erk signaling separates the induction and maintenance of cell senescence after DNA damage induced by topoisomerase II inhibition.Tatiana S Netterfield, Gerard J Ostheimer, Andrea R Tentner, Brian A Joughin, Alexandra M Dakoyannis, Charvi D Sharma, Peter K Sorger, Kevin A Janes, Douglas A Lauffen...> ;Cell Systems. 2023 Jul 19
- 1 citationsSeeing is great, understanding is better.H Holden Thorp, Michael B Yaffe> ;Science Signaling. 2023 Jan 10
- Join now to see all
Press Mentions
- 3 Questions: Michael Yaffe on Treating Covid-19 Patients with Acute Respiratory DistressApril 29th, 2020
- Repurposing a Drug for Blood Clots: A Stopgap Measure to Treat Respiratory Distress in COVID-19March 30th, 2020
- Blood Clot-Dissolving Drug May Treat Critical Covid-19 PatientsMarch 27th, 2020
- Join now to see all
Grant Support
- DNA Damage NetworksNational Cancer Institute2010–2012
- Biopolymers &ProteomicsNational Cancer Institute2010–2012
- Project 7National Institute Of General Medical Sciences2008–2011
- Protein Kinase Signaling And Cell Cycle ControlNational Institute Of Environmental Health Sciences2007–2011
- Cell Growth &Proliferation Gordon Research ConferenceNational Cancer Institute2007–2011
- Neutrophil Priming In Trauma And SepsisNational Institute Of General Medical Sciences2000–2011
- Core--Biopolymer LaboratoryNational Cancer Institute2007–2009
- High-Content Screening For Modifiers Of The DNA Damage ResponseNational Institute Of Neurological Disorders And Stroke2008
- 2004 Growth Factor Signalling Gordon ConferenceNational Cancer Institute2006–2008
- Structure Of The Sigma Isoform Of The Phosphopeptide-Binding Protein 14-3-3National Center For Research Resources2005–2008
- DNA Repair SignalingNational Cancer Institute2004–2008
- Phosphoserine Dependant Assembly Of Signaling ComplexesNational Institute Of General Medical Sciences2004–2007
- Ncrr Shared Instrumentation Grant (SIG) PROGRAM: Structural BiologyNational Center For Research Resources2005
- Ncrr Shared Instrumentation Grant (SIG) ProgramNational Center For Research Resources2005
- Ncrr (SIG) PROGRAM: Struct Biol: Clp-X ProjectsNational Center For Research Resources2005
- Identification Of Molecular Pathways In Cancer BiologyNational Cancer Institute2004–2005
- High-Throughput Assay Design:Polo Kinase Inhibitors(Rmi)National Institute Of Neurological Disorders And Stroke2004
- Sigma Isoform Of Phosphopeptide-Binding Protein 14-3-3National Center For Research Resources2004
- Phosphoserine Dependent Assembly Of Signaling ComplexesNational Institute Of General Medical Sciences2000–2003
- Phosphoserine Dependent Assembly Of Signaling ComplexesNational Institute Of General Medical Sciences2000
- Neutrophil Priming In Trauma And SepsisNational Institute Of General Medical Sciences1999–2000
- Heat Shock Protein HSP-90 Following InjuryNational Heart, Lung, And Blood Institute1997–1999
- Heat Shock Protein HSP90 Following InjuryNational Heart, Lung, And Blood Institute1998
Hospital Affiliations
- Beth Israel Deaconess Medical CenterBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: